What is Dolutegravir (DTG)?

Dolutegravir (DTG) is an antiviral drug used with other medications to treat human immunodeficiency virus (HIV) infection.

What is Dolutegravir (DTG)?

About Dolutegravir (DTG)

  • It is an antiviral drug used with other medications to treat human immunodeficiency virus (HIV) infection, the virus that can cause the acquired immunodeficiency syndrome (AIDS).
  • Dolutegravir is in a class of medications called HIV integrase inhibitors.
  • It works by decreasing the amount of HIV in your blood and increasing the number of immune cells that help fight infections in your body.
  • Although dolutegravir does not cure HIV, using it along with other medications may decrease your chance of developing AIDS and HIV-related illnesses such as serious infections or cancer.
  • Since 2018, WHO has recommended the use of dolutegravir as the preferred first- and second-line HIV treatment for all population groups. 
  • It is more effective, easier to take, and has fewer side effects than other drugs currently in use.
  • Common side effects of dolutegravir may include:
    • headache;
    • tiredness; or
    • sleep problems (insomnia).
    • Some side effects can be serious. These include severe skin rashes and allergic reactions, liver problems, and drug interactions.

What is HIV/AIDS?

  • AIDS is a chronic, potentially life-threatening condition caused by HIV.
  • HIV attacks the body’s immune system, making a person more vulnerable to other infections and diseases.
  • If HIV is not treated, it can lead to AIDS.
  • Transmission:
    • It is a sexually transmitted infection (STI).
    • It can also be spread by contact with infected blood, and from illicit injection drug use, or by sharing needles.
    • It can also be spread from mother to child during pregnancy, childbirth, or breastfeeding. 
  • Treatment:
    • There is currently no effective cure. Once people get HIV, they have it for life.
    • But with proper medical care, HIV can be controlled. People with HIV who get effective HIV treatment (called antiretroviral therapy, or ART) can live long, healthy lives and protect their partners.

Q1) What is a Virus?

A virus is an infectious microbe consisting of a segment of nucleic acid (either DNA or RNA) surrounded by a protein coat. A virus cannot replicate alone; instead, it must infect cells and use components of the host cell to make copies of itself. Often, a virus ends up killing the host cell in the process, causing damage to the host organism. Well-known examples of viruses causing human disease include AIDS, COVID-19, measles and smallpox.

Source: WHO highlights growing HIV drug resistance to dolutegravir, urges global action

Latest UPSC Exam 2025 Updates

Last updated on July, 2025

UPSC Notification 2025 was released on 22nd January 2025.

UPSC Prelims Result 2025 is out now for the CSE held on 25 May 2025.

UPSC Prelims Question Paper 2025 and Unofficial Prelims Answer Key 2025  are available now.

UPSC Calendar 2026 is released on 15th May, 2025.

→ The UPSC Vacancy 2025 were released 1129, out of which 979 were for UPSC CSE and remaining 150 are for UPSC IFoS.

UPSC Mains 2025 will be conducted on 22nd August 2025.

UPSC Prelims 2026 will be conducted on 24th May, 2026 & UPSC Mains 2026 will be conducted on 21st August 2026.

→ The UPSC Selection Process is of 3 stages-Prelims, Mains and Interview.

UPSC Result 2024 is released with latest UPSC Marksheet 2024. Check Now!

UPSC Toppers List 2024 is released now. Shakti Dubey is UPSC AIR 1 2024 Topper.

→ Also check Best IAS Coaching in Delhi

Vajiram Editor
Vajiram Editor
UPSC GS Course 2026
UPSC GS Course 2026
₹1,75,000
Enroll Now
GS Foundation Course 2 Yrs
GS Foundation Course 2 Yrs
₹2,45,000
Enroll Now
Prelims PowerupTest Series
Prelims PowerupTest Series
₹13000
Enroll Now
UPSC Mains Test Series
UPSC Mains Test Series
₹16000
Enroll Now
UPSC Mentorship Program
UPSC Mentorship Program
₹85000
Enroll Now
Enquire Now